Suppression of experimental autoimmune encephalomyelitis by Ghrelin

Journal of Immunology

Volumn 183, Issue 4, 2009, Pages 2859-2866

  Theil, Michael Mark ^a,b   Miyake, Sachiko ^a   Mizuno, Miho ^a   Tomi, Chiharu ^a   Croxford, J Ludovic ^a   Hosoda, Hiroshi ^c   Theil, Julia ^a,b   Von Hörsten, Stephan ^b,d   Yokote, Hiroaki ^a   Chiba, Asako ^a   Lin, Youwei ^a   Oki, Shinji ^a   Akamizu, Takashi ^e   Kangawa, Kenji ^e   Yamamura, Takashi ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e KYOTO UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; GHRELIN, DES N OCTANOYL; GHRELIN, DES-N-OCTANOYL; NONSTEROID ANTIINFLAMMATORY AGENT;

ALLERGIC ENCEPHALITIS; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; AMINO ACID SEQUENCE; ANIMAL; C57BL MOUSE; CELL LINE; DRUG ANTAGONISM; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; PATHOLOGY;

AMINO ACID SEQUENCE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GHRELIN; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MICROGLIA; MOLECULAR SEQUENCE DATA; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70149084413     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803362     Document Type: Article

References (38)

1. Deghenghi, R., M. M. Cananzi, A. Torsello, C. Battisti, E. E. Muller, and V. Locatelli. 1994. GH-releasing activity of Hexarelin, a new growth hormone releasing peptide, in infant and adult rats. Life Sci. 54: 1321-1328.
2. Howard, A. D., S. D. Feighner, D. F. Cully, J. P. Arena, P. A. Liberator, C. I. Rosenblum, M. Hamelin, D. L. Hreniuk, O. C. Palyha, J. Anderson, et al. 1996. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273: 974-977.
3. Smith, R. G., K. Cheng, W. R. Schoen, S. S. Pong, G. Hickey, T. Jacks, B. Butler, W. W. Chan, L. Y. Chaung, F. Judith, et al. 1993. A nonpeptidyl growth hormone secretagogue. Science 260: 1640-1643.
4. Kojima, M., H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, and K. Kangawa. 1999. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402: 656-660. (Pubitemid 129516334)
5. Date, Y., M. Kojima, H. Hosoda, A. Sawaguchi, M. S. Mondal, T. Suganuma, S. Matsukura, K. Kangawa, and M. Nakazato. 2000. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141: 4255-4261.
6. Hattori, N., T. Saito, T. Yagyu, B. H. Jiang, K. Kitagawa, and C. Inagaki. 2001. GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils. J. Clin. Endocrinol. Metab. 86: 4284-4291.
7. Hosoda, H., M. Kojima, H. Matsuo, and K. Kangawa. 2000. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem. Biophys. Res. Commun. 279: 909-913.
8. Nakazato, M., N. Murakami, Y. Date, M. Kojima, H. Matsuo, K. Kangawa, and S. Matsukura. 2001. A role for ghrelin in the central regulation of feeding. Nature 409: 194-198.
9. Tschop, M., D. L. Smiley, and M. L. Heiman. 2000. Ghrelin induces adiposity in rodents. Nature 407: 908-913.
10. Muccioli, G., M. Tschop, M. Papotti, R. Deghenghi, M. Heiman, and E. Ghigo. 2002. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur. J. Pharmacol. 440: 235-254.
11. Nagaya, N., T. Itoh, S. Murakami, H. Oya, M. Uematsu, K. Miyatake, and K. Kangawa. 2005. Treatment of cachexia with ghrelin in patients with COPD. Chest 128: 1187-1193.
12. Cowley, M. A., R. G. Smith, S. Diano, M. Tschop, N. Pronchuk, K. L. Grove, C. J. Strasburger, M. Bidlingmaier, M. Esterman, M. L. Heiman, et al. 2003. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37: 649-661.
13. Shintani, M., Y. Ogawa, K. Ebihara, M. Aizawa-Abe, F. Miyanaga, K. Takaya, T. Hayashi, G. Inoue, K. Hosoda, M. Kojima, et al. 2001. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 50: 227-232.
14. Dixit, V. D., E. M. Schaffer, R. S. Pyle, G. D. Collins, S. K. Sakthivel, R. Palaniappan, J. W. Lillard, Jr., and D. D. Taub. 2004. Ghrelin inhibits leptin-and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J. Clin. Invest. 114: 57-66.
15. Wassem, T., M. Duxbury, H. Ito, S. W. Ashley, and M. K. Robinson. 2008. Exogeneous ghrelin modulates release of pro- and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways. Surgery 143: 334-342.
16. Chorny, A., P. Anderson, E. Gonzalez-Rey, and M. Delgado. 2008. Ghrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteria. J. Immunol. 180: 8369-8377.
17. Gonzalez-rey, E., A. Chorny, and M. Delgado. 2006. Therapeutic action of ghrelin in a mouse model of colitis. Gastroenterology 130: 1707-1720.
18. Granado, M., T., Priego, A. I., Martin, A., Villanua, and A. Lopez-Caldron. 2005. Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats. Am. J. Physiol. 288: E486-E492.
19. Li, W. G., D. Gavrila, X. Liu, L. Wang, S. Gunnlaugsson, L. L. Stoll, M. L. McCormick, C. D. Sigmund, C. Tang, and N. L. Weintraub. 2004. Ghrelin inhibits proinflammatory responses and nuclear factor-κB activation in human endothelial cells. Circulation 109: 2221-2226.
20. Wu, R., W. Dong, X. Cui, M. Zhou, H. H. Simms, T. S. Ravikumar, and P. Wang. 2007. Ghrelin down-regulates proinflammatory cytokines in sepsis through activation of the vagus nerve. Ann. Surg. 245: 480-486.
21. Mendel, I., N. Kerlero de Rosbo, and A. Ben-Nun. 1995. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor Vβ expression of encephalitogenic T cells. Eur. J. Immunol. 25: 1951-1959.
22. Zhang, B., T. Yamamura, T. Kondo, M. Fujiwara, and T. Tabira. 1997. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J. Exp. Med. 186: 1677-1687.
23. Miyamoto, K., S. Miyake, M. Mizuno, N. Oka, S. Kusunoki, and T. Yamamura. 2006. Selective COX-2 inhibitor celecoxib prevents experimental autoimmune encephalomyelitis through COX-2-independent pathway. Brain 129: 1984-1992.
24. Chan, J. L., G. Matarese, G. K. Shetty, P. Raciti, I. Kelesidis, D. Aufiero, V. De Rosa, F. Perna, S. Fontana, and C. S. Mantzoros. 2006. Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans. Proc. Natl. Acad. Sci. USA 103: 8481-8486.
25. Kuchroo, V. K., and L. B. Nicholson. 2003. Immunology: fast and feel good? Nature 422: 27-28.
26. Wing, E. J., D. M. Magee, and L. K. Barczynski. 1988. Acute starvation in mice reduces the number of T cells and suppresses the development of T-cell-mediated immunity. Immunology 63: 677-682.
27. Lord, G. M., G. Matarese, J. K. Howard, R. J. Baker, S. R. Bloom, and R. I. Lechler. 1998. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394: 897-901.
28. Sanna, V., A. Di Giacomo, A. La Cava, R. I. Lechler, S. Fontana, S. Zappacosta, and G. Matarese. 2003. Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J. Clin. Invest. 111: 241-250.
29. Bedoui, S., S. Miyake, Y. Lin, K. Miyamoto, S. Oki, N. Kawamura, A. Beck-Sickinger, S. von Horsten, and T. Yamamura. 2003. Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis: NPY1 receptor-specific inhibition of autoreactive Th1 responses in vivo. J. Immunol. 171: 3451-3458.
30. Kalra, S. P., and P. S. Kalra. 2003. Neuropeptide Y: a physiological orexigen modulated by the feedback action of ghrelin and leptin. Endocrine 22: 49-56.
31. Kalra, S. P., N. Ueno, and P. S. Kalra. 2005. Stimulation of appetite by ghrelin is regulated by leptin restraint: peripheral and central sites of action. J. Nutr. 135: 1331-1335.
32. Chang, L., J. Zhao, J. Yang, Z. Zhang, J. Du, and C. Tang. 2003. Therapeutic effects of ghrelin on endotoxic shock in rats. Eur. J. Pharmacol. 473: 171-176. (Pubitemid 36929881)
33. Glabinski, A. R., B. Bielecki, J. A. Kawczak, V. K. Tuohy, K. Selmaj, and R. M. Ransohoff. 2004. Treatment with soluble tumor necrosis factor receptor (sTNFR):Fc/p80 fusion protein ameliorates relapsing-remitting experimental autoimmune encephalomyelitis and decreases chemokine expression. Autoimmunity 37: 465-471.
34. Xanthoulea, S., M. Pasparakis, S. Kousteni, C. Brakebusch, D. Wallach, J. Bauer, H. Lassmann, and G. Kollias. 2004. Tumor necrosis factor (TNF) receptor shedding controls thresholds of innate immune activation that balance opposing TNF functions in infectious and inflammatory diseases. J. Exp. Med. 200: 367-376.
35. 35-55-induced experimental autoimmune encephalomyelitis in C57BL/6 mice. Gene Ther. 14: 93-98.
36. Okuda, Y., S. Sakoda, H. Fujimura, Y. Saeki, T. Kishimoto, and T. Yanagihara. 1999. IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glucoprotein 35-55 induced experimental autoimmune encephalomyelitis. J. Neuroimmunol. 101: 188-196.
37. Okuda, Y., S. Sakoda, Y. Saeki, T. Kishimoto, and T. Yanagihara. 2000. Enhancement of Th2 response in IL-6-deficient mice immunized with myelin oligodendrocyte glycoprotein. J. Neuroimmunol. 105: 120-123.
38. Sutton, C., C. Brereton, B. Keogh, K. H. Mills, and E. C. Lavelle. 2006. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate aoimmune encephalomyelitis. J. Exp. Med. 203: 1685-1691.